Tumor-infiltrating Foxp3+ regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer K Shimizu, M Nakata, Y Hirami, T Yukawa, A Maeda, K Tanemoto Journal of Thoracic Oncology 5 (5), 585-590, 2010 | 281 | 2010 |
Percutaneous CT-guided fine needle aspiration for lung cancer smaller than 2 cm and revealed by ground-glass opacity at CT K Shimizu, N Ikeda, M Tsuboi, T Hirano, H Kato Lung cancer 51 (2), 173-179, 2006 | 158 | 2006 |
PD-L1 overexpression is partially regulated by EGFR/HER2 signaling and associated with poor prognosis in patients with non-small-cell lung cancer R Okita, A Maeda, K Shimizu, Y Nojima, S Saisho, M Nakata Cancer Immunology, Immunotherapy 66, 865-876, 2017 | 148 | 2017 |
Preoperative neutrophil/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancer K Shimizu, R Okita, S Saisho, A Maeda, Y Nojima, M Nakata World journal of surgical oncology 13, 1-8, 2015 | 113 | 2015 |
Adoptive immunotherapy of cancer using activated autologous lymphocytes-current status and new strategies Y Yamaguchi, A Ohshita, Y Kawabuchi, K Ohta, K Shimizu, K Minami, ... Human Cell 16, 183-189, 2003 | 87 | 2003 |
MHC class I chain-related molecule A and B expression is upregulated by cisplatin and associated with good prognosis in patients with non-small cell lung cancer R Okita, T Yukawa, Y Nojima, A Maeda, S Saisho, K Shimizu, M Nakata Cancer Immunology, Immunotherapy 65, 499-509, 2016 | 67 | 2016 |
Post-recurrence survival of patients with non-small-cell lung cancer after curative resection with or without induction/adjuvant chemotherapy S Saisho, K Yasuda, A Maeda, T Yukawa, R Okita, Y Hirami, K Shimizu, ... Interactive cardiovascular and thoracic surgery 16 (2), 166-172, 2013 | 65 | 2013 |
Serum antibody against NY-ESO-1 and XAGE1 antigens potentially predicts clinical responses to anti–programmed cell death-1 therapy in NSCLC Y Ohue, K Kurose, T Karasaki, M Isobe, T Yamaoka, J Futami, I Irei, ... Journal of Thoracic Oncology 14 (12), 2071-2083, 2019 | 44 | 2019 |
Locoregional immunotherapy of malignant effusion from colorectal cancer using the streptococcal preparation OK-432 plus Interleukin-2 Y Yamaguchi, E Miyahara, A Ohshita, Y Kawabuchi, K Ohta, K Shimizu, ... British journal of cancer 89 (10), 1876-1884, 2003 | 40 | 2003 |
Clinicopathological and immunohistochemical features of lung invasive mucinous adenocarcinoma based on computed tomography findings K Shimizu, R Okita, S Saisho, A Maeda, Y Nojima, M Nakata OncoTargets and therapy, 153-163, 2016 | 38 | 2016 |
Contrasting effects of the cytotoxic anticancer drug gemcitabine and the EGFR tyrosine kinase inhibitor gefitinib on NK cell-mediated cytotoxicity via regulation of NKG2D … R Okita, D Wolf, K Yasuda, A Maeda, T Yukawa, S Saisho, K Shimizu, ... PLoS One 10 (10), e0139809, 2015 | 37 | 2015 |
Clinical significance of dual-time-point 18F-FDG PET imaging in resectable non-small cell lung cancer K Shimizu, R Okita, S Saisho, T Yukawa, A Maeda, Y Nojima, M Nakata Annals of Nuclear Medicine 29, 854-860, 2015 | 36 | 2015 |
Influence of vascular endothelial growth factor single nucleotide polymorphisms on non-small cell lung cancer tumor angiogenesis A Maeda, M Nakata, K Yasuda, T Yukawa, S Saisho, R Okita, Y Hirami, ... Oncology reports 29 (1), 39-44, 2013 | 36 | 2013 |
Cavernous hemangioma of the rib K Shimizu, Y Yamashita, J Hihara, Y Seto, T Toge The Annals of thoracic surgery 74 (3), 932-934, 2002 | 33 | 2002 |
Heterogeneity of the EGFR mutation status between the primary tumor and metastatic lymph node and the sensitivity to EGFR tyrosine kinase inhibitor in non-small … K Shimizu, T Yukawa, Y Hirami, R Okita, S Saisho, A Maeda, K Yasuda, ... Targeted oncology 8, 237-242, 2013 | 31 | 2013 |
Prognostic value of Cox-2 and PD-L1 expression and its relationship with tumor-infiltrating lymphocytes in resected lung adenocarcinoma K Shimizu, R Okita, S Saisho, A Maeda, Y Nojima, M Nakata Cancer Management and Research, 741-750, 2017 | 28 | 2017 |
Prognostic nutritional index before adjuvant chemotherapy predicts chemotherapy compliance and survival among patients with non-small-cell lung cancer K Shimizu, R Okita, S Saisho, T Yukawa, A Maeda, Y Nojima, M Nakata Therapeutics and clinical risk management, 1555-1561, 2015 | 28 | 2015 |
Impact of COX2 inhibitor for regulation of PD-L1 expression in non-small cell lung cancer K Shimizu, R Okita, S Saisho, AI Maeda, Y Nojima, M Nakata Anticancer Research 38 (8), 4637-4644, 2018 | 27 | 2018 |
Lapatinib enhances trastuzumab-mediated antibody-dependent cellular cytotoxicity via upregulation of HER2 in malignant mesothelioma cells R Okita, K Shimizu, Y Nojima, T Yukawa, A Maeda, S Saisho, M Nakata Oncology reports 34 (6), 2864-2870, 2015 | 27 | 2015 |
Clinical significance of the tumor microenvironment in non-small cell lung cancer K Shimizu, R Okita, M Nakata Annals of translational medicine 1 (2), 2013 | 27 | 2013 |